MEDANTA.NS

HoldPremium Grower

Global Health Limited · Healthcare · India · $4.2B · Avg Vol: $4M/d

Premium Grower: Strong business with the market behind it, priced at a premium.

64
StockRank
Get score and insider alerts
Quality
66
Value
17
Momentum
74

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
65.9x
peers 42.9x
ROE
14.0%
peers 11.7%
D/E
0.3x
peers 0.2x
Dividend %
0.0%
trailing yield

ABOUT GLOBAL HEALTH LIMITED

Read

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone...

FINANCIAL SUMMARY (INR)

Year2023202420252026CAGRTTM2027E2028EFwd CAGR
Revenue26.8B32.4B36.4B43.2B17.2%46.8B52.0B60.1B17.9%
EPS (INR)12.5817.8017.9220.7118.1%20.6126.7733.6427.5%
Shares268.2M268.5M268.6M268.6M+0.2%268.7M———
Debt11.2B8.0B7.2B11.9B2.0%11.9B———
Equity24.3B29.1B33.9B39.6B17.7%————
Op CF6.4B6.1B6.2B7.1B3.5%7.2B———
Inv CF-3.4B-4.4B-7.2B-10.9B—————
Fin CF3.5B-5.1B-972.3M2.7B—————
Loading 1Y...
PRICE (1Y) · INR-4.2%
1,3571,3951,4331,4711,50919 Aug10 Sep1 Oct
SMA 50SMA 200

Price checkExperimental
SwingsAverage

Calmer than 71% of stocks we rank over the past year (30% a year).

How this is worked out

What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
INR 1,357.30
RSI (14)
35.2
52-Week Range-12.1% from high
Low INR 955.66High INR 1,544.00

SCORE BREAKDOWN

Quality
66
ROIC
15.4%83.6
ROE
14.0%80.1
GP/Assets
41.3%80.0
Op. Margin
16.7%78.8
FCF/Assets
-4.5%36.2
Piotroski
668.7
Int. Cover
8.8x60.6
D/E Ratio
0.30x41.2
Current Ratio
2.67x51.2
Value
17
P/E (TTM)
65.9x15.0
EV/EBITDA
37.7x16.1
P/FCF
—N/A
P/B
9.2x11.8
P/S
7.8x30.1
Div Yield
0.0%0.6
Momentum
74
52W High %
88%82.7
RS 6M
35%87.5
SMA 50/200
1.16x85.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+63%62.3
Q Growth
-0%36.8

FUNDAMENTALS

Market Cap
$4.2B
P/E (Forward)
40.4x
Gross Margin
52.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MEDANTA.NS are excluded.

TickerCompanyMkt CapStockRankSignal
MEDANTA.NSGlobal Health Limited(you)$4.2B64Hold
NH.NSNarayana Hrudayalaya Limited$4.0B60Hold
RAINBOW.NSRainbow Children's Medicare Limited$1.5B66Buy
KIMS.NSKrishna Institute of Medical Sciences Limited$3.5B45Hold
APOLLOHOSP.NSApollo Hospitals Enterprise Limited$13.3B66Buy
FORTIS.NSFortis Healthcare Limited$6.9B47Hold
ASTERDM.NSAster DM Quality Care Limited$7.0B44Hold
YATHARTH.NSYatharth Hospital & Trauma Care Services Limited$1.2B71Buy
HCG.NSHealthCare Global Enterprises Limited$1.1B57Hold
MAXHEALTH.NSMax Healthcare Institute Limited$10.6B43Hold

Peer medians: ROE 11.7% · P/E 42.9x · Gross margin 59.4%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Global Health Limited (MEDANTA.NS): Stock Score Summary

Global Health Limited (MEDANTA.NS) has a MoatMap StockRank of 64/100 based on Quality (66/100), Value (17/100), and Momentum (74/100) factor scores. The current signal is HOLD.

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone...

Key Financial Metrics

PriceINR 1,357.30
Market Cap$4.2B
P/E (TTM)65.86
P/E (Forward)40.38
Price/Book9.20
Return on Equity14.0%
Return on Invested Capital15.4%
Debt/Equity0.30x
Gross Margin52.8%
Operating Margin16.7%
Revenue Growth26.5%
Dividend Yield0.0%
Free Cash Flow$-28M

Global Health Limited operates in the Medical Care Facilities industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Global Health Limited’s (MEDANTA.NS) StockRank?
MoatMap’s StockRank for Global Health Limited (MEDANTA.NS) is 64/100, with a Hold signal. It is a composite of Quality (66), Value (17), and Momentum (74) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Global Health Limited have an economic moat?
Global Health Limited (MEDANTA.NS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Global Health Limited a buy, hold, or sell?
MoatMap’s current signal for Global Health Limited (MEDANTA.NS) is Hold, based on a StockRank of 64/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Global Health Limited in?
Global Health Limited (MEDANTA.NS) operates in the Healthcare sector, specifically the Medical Care Facilities industry (India).